Gini Deshpande's guest appearances

Gini Deshpande

Tech Tonics

The Harry Glorikian Show

Joel Dudley

John Glaser

Rayid Ghani

Daphne Koller

Michelle Meyer

Brian Smith

Matteo Franceschetti

Azeem Azhar

Rana El Kaliouby

Stephanie Tilenius

David Sable

Harpreet Rai

Beth Israel

Michael Snyder

Dave Albert

OwlTail

Gini Desphande says she likes to think of "AI" as augmented intelligence rather than artificial intelligence: a system of human plus machine intelligence that can speed up drug development and cut R&amp;D costs and failure rates in clinical trials. AI "really isn't at the point where it's automatable," she says. "We still need a lot of human intelligence to be coupled with this technology, to determine what are the questions you want to ask and to evaluate all the targets that come out, to say 'Do these make sense?'"NuMedii's specialty is analyzing bulk tissue to isolate gene sequences in single cells that can point to new drug targets and drug candidates for diseases such as idiopathic pulmonary fibrosis. "The AI component helps us look at new targets that are not obvious to the human eye," she says. "It enables us to find network-level connections between diseases of interest and targets that are relevant for that disease. We can look at which nodes are coming into play and which ones should be manipulated for a particular disease."This episode is part of a special series of interviews with speakers at the AI Applications Summit produced by Corey Lane Partners. Check out the full show notes and other MoneyBall Medicine episodes at our website.Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac.2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings &amp; Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars.6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner.8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out.9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.

Gini Desphande says she likes to think of "AI" as augmented intelligence rather than artificial intelligence: a system of human plus machine intelligence that can speed up drug development and cut R&amp;D costs and failure rates in clinical trials. AI "really isn't at the point where it's automatable," she says. "We still need a lot of human intelligence to be coupled with this technology, to determine what are the questions you want to ask and to evaluate all the targets that come out, to say 'Do these make sense?'"NuMedii's specialty is analyzing bulk tissue to isolate gene sequences in single cells that can point to new drug targets and drug candidates for diseases such as idiopathic pulmonary fibrosis. "The AI component helps us look at new targets that are not obvious to the human eye," she says. "It enables us to find network-level connections between diseases of interest and targets that are relevant for that disease. We can look at which nodes are coming into play and which ones should be manipulated for a particular disease."This episode is part of a special series of interviews with speakers at the AI Applications Summit produced by Corey Lane Partners. Check out the full show notes and other MoneyBall Medicine episodes at <a href="http://www.glorikian.com/podcast" rel="nofollow" target="_blank">our website</a>.Please rate and review <a href="https://podcasts.apple.com/us/podcast/a-new-era-of-participatory-medicine-talking-with/id1435939790?i=1000538326858" rel="nofollow" target="_blank">The Harry Glorikian Show on Apple Podcasts</a>! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac.2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings &amp; Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars.6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner.8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out.9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

The daughter of a commercial airline pilot and the oldest of two kids, Gini Deshpande grew up in Mumbai and told her parents that by the time she was forty, she wanted to own her own car, house, and company.  Check, check, and check. After completing college and a competitive masters program in molecular biology in India, she turned down a full scholarship there in order to continue her studies in the United States, at Purdue specifically.  Gini has pointed out that Purdue is in the heartland and thus an amusing place for a vegetarian to reside. Gini figured out pretty quickly that she didn’t want to be an academic, and was especially interested in translation, a way of thinking that she says “didn’t resonate with the purist mindset” present in much of academia.  She adds, “if you want to think about application, it’s considered a big no-no.” A pivotal experience in the tech transfer office at Children’s Hospital in Boston helped launch her on a path towards entrepreneurship, ultimately leading to her role as Founder and CEO of NuMedii, which seeks to use multi-omics and artificial intelligence to drive drug discovery. A high-profile biotech entrepreneur (a role that’s reflected even in her twitter handle: @biotechfounder), Gini has been a particularly impassioned champion of mentorship, for entrepreneurs in general, and for female entrepreneurs in particular. We are delighted welcome Gini to Tech Tonics!  We are grateful to our sponsor, DNAnexus, for support of today’s show.  DNAnexus is the secure and compliant cloud platform that enables enterprise users to analyze, collaborate around, and integrate massive amounts of genetic and other health data.

The daughter of a commercial airline pilot and the oldest of two kids, <a href="https://www.linkedin.com/in/tarangini-gini-deshpande-00bb54/" rel="nofollow" target="_blank">Gini Deshpande</a> grew up in Mumbai and told her parents that by the time she was forty, she wanted to own her own car, house, and company. Check, check, and check. After completing college and a competitive masters program in molecular biology in India, she turned down a full scholarship there in order to continue her studies in the United States, at Purdue specifically. Gini has pointed out that Purdue is in the heartland and thus an amusing place for a vegetarian to reside. Gini figured out pretty quickly that she didn’t want to be an academic, and was especially interested in translation, a way of thinking that she says “didn’t resonate with the purist mindset” present in much of academia. She adds, “if you want to think about application, it’s considered a big no-no.” A pivotal experience in the tech transfer office at Children’s Hospital in Boston helped launch her on a path towards entrepreneurship, ultimately leading to her role as Founder and CEO of <a href="http://numedii.com/" rel="nofollow" target="_blank">NuMedii</a>, which seeks to use multi-omics and artificial intelligence to drive drug discovery. A high-profile biotech entrepreneur (a role that’s reflected even in her twitter handle: @biotechfounder), Gini has been a particularly impassioned champion of mentorship, for entrepreneurs in general, and for female entrepreneurs in particular. We are delighted welcome Gini to Tech Tonics! We are grateful to our sponsor, <a href="http://dnanexus.com/" rel="nofollow" target="_blank">DNAnexus</a>, for support of today’s show. DNAnexus is the secure and compliant cloud platform that enables enterprise users to analyze, collaborate around, and integrate massive amounts of genetic and other health data.

Tech Tonics: Gini Deshpande, @biotechfounder